Urine vs. Blood Analysis: Comparative Insights for Wellness Apps

Curious about Calcium and its impact on your wellness?

Discover its importance in maintaining calcium. intake

Article CTA

Urine vs. Blood Analysis: Comparative Insights for Wellness Apps

img author
Haluk Çelik

Written by Senior R&D Engineer, Haluk Çelik on April 29, 2025.

Medical diagnostics often rely on analyzing biological fluids, primarily blood and urine, due to their accessibility and rich information content (Lenaerts et al., 2020; Balhara et al., 2023). Blood tests are widely recognized for their accuracy and ability to measure systemic parameters, while urine tests offer a non-invasive alternative for monitoring metabolic and renal function (Gao, 2018). Vivoo uses urine analysis for wellness insights because it enables frequent, user-friendly monitoring without the need for clinical intervention.

Urine and blood are two essential biofluids used in medical diagnostics, each providing valuable insights into the body's physiological state. While blood reflects a comprehensive overview of organ functions and metabolic processes through a systemic approach (Poletaev, 2018; Sequeira-Antunes and Ferreira, 2023; Santos-Silva et al., 2024), urine offers a distinct advantage: it is a non-invasive, easily obtainable sample that reliably mirrors both kidney function and a wide range of systemic health markers (Sequeira-Antunes and Ferreira, 2023). Due to its accessibility, patient comfort, and rich biomarker content, urine testing presents a more practical and patient-friendly alternative for routine health monitoring and disease detection (Sharp et al., 2020; Yeasmin et al., 2022). Urine serves as a sensitive and non-invasive biological matrix with considerable potential for yielding diagnostic information. 

The composition of urine reflects the body's metabolic status, offering a rich source of diagnostic and prognostic information (Balhara et al., 2023). By choosing urine for testing, Vivoo empowers individuals to take control of their health easily, frequently, and accurately, bridging the gap between advanced diagnostics and everyday wellness. Importantly, urine test strips are a valuable tool for diagnosing various medical conditions, and their results are generally correlated with the gold-standard methods used in clinical settings (Zamanzad, 2009; Kara et al., 2013; Lepowsky et al., 2017; Akagawa et al.i 2020). Many metabolic, nutritional, and physiological parameters reflected in blood can also be detected in urine, making it a practical proxy for evaluating aspects of systemic health (Simerville et al., 2005).

What’s The Difference Between A Blood Test And A Urine Test?

Urine analysis is non-invasive and easy to collect, causing no discomfort, unlike blood collection, which requires skin puncture and stricter procedures (Simerville et al., 2005; Zhang et al., 2022). This makes urine preferable for repeated sampling and ongoing health monitoring (Zhang et al., 2022; Shao et al., 2021).

Blood tests measure biomarkers directly circulating in the body, reflecting real-time physiological status (Greene et al., 2019). Urine tests, on the other hand, assess the metabolic by-products excreted by the kidneys, providing information on hydration, nutrient balance, and metabolic health over time. While blood analysis generally provides more immediate snapshots, urine analysis reveals cumulative physiological changes.

While every compound found in urine can also be found in blood, urine contains additional compounds not typically present in blood. This difference likely arises from the kidneys' role in filtering blood and concentrating certain metabolites for excretion (Shao et al., 2021).

Urine, being less affected by regulatory mechanisms, can accumulate a wider array of disease-related information, reflecting many bodily changes and potentially facilitating the discovery of diagnostic markers (Shao et al., 2021). Furthermore, urine analysis provides detailed insights into kidney function and can reveal the presence of various metabolites and proteins related to different diseases as blood is filtered by the kidneys and waste products are concentrated in the urine (Zhang et al., 2022).

Why Analyze Urine?

Urine offers a rich matrix of metabolites, electrolytes, and waste products that can indicate hydration status, renal function, infection, and nutritional deficiencies (Bouatra et al., 2013). Urine collection is non-invasive, inexpensive, and allows for repeated sampling without causing patient discomfort (Khamis et al., 2017). Moreover, urine metabolomics has gained popularity for monitoring wellness and chronic disease risk without the need for venipuncture (Dunn et al., 2011).

Urine is increasingly recognized as a rich source of cellular metabolites and a highly useful biofluid for routine testing, with a growing number of protein markers identified within it that can improve early diagnosis (Sequeira-Antunes and Ferreira, 2023). This evolution reflects a growing appreciation for the diagnostic potential of urine alongside the well-established utility of blood. 

The human urine metabolome encompasses a vast array of compounds. According to the Human Metabolome Database (HMDB), 5662 metabolites have been identified in human urine (date retrieved at 2 May 2025). These metabolites span various chemical classes such as amino acids, organic acids, carbohydrates and sugar alcohols, nucleosides and bases, vitamins, hormones and steroids, drug metabolites (Wishart et al., 2007; 2009; 2012; 2018; 2022). Also, some cancer types can be detected in urine using specific biomarkers such as;

  • For bladder cancer: Nuclear Matrix Protein 22 (NMP22), Bladder Tumor Antigen (BTA Stat and BTA TRAK), and specific microRNAs are used to detect and monitor the disease. These markers help identify bladder cancer by detecting abnormal proteins or nucleic acids shed into the urine (Vinagre, 2020; Zambrano et al., 2021; Ahangar et al., 2024).

  • For prostate cancer: Prostate Cancer Antigen 3 (PCA3) and urinary exosomal proteins serve as non-invasive indicators. PCA3 is a prostate-specific non-coding RNA that is significantly upregulated in cancerous tissue, while exosomal proteins reflect molecular changes in the tumor microenvironment (Filella and Foj, 2016; Lemos et al., 2019; Gan et al., 2022).

  • For kidney cancer: The proteins Aquaporin-1 and Perilipin-2 have been identified as promising urinary biomarkers, showing elevated levels in patients with renal cell carcinoma. These markers offer a potential route for early detection through a simple urine sample (Morissey et al., 2013; 2014; Cheriyan et al., 2021; Flitcroft et al., 2022).

How Is A Urine Test Conducted?

Urine testing typically involves sample collection in a sterile container followed by analysis using dipsticks, chemical assays, or laboratory instruments (Simerville et al., 2005; Strasinger and Di Lorenzo, 2014; Ridley, 2018). Dipsticks impregnated with reagents enable immediate semi-quantitative assessment of multiple parameters such as pH, glucose, protein, and ketones (Price, 2001). Using the Vivoo Wellness Test, there is no need for urine collection. Simply urinate on the test strip, scan it after 90 seconds, and receive your results and personalized nutrition advice through the Vivoo app.

Advantages And Limitations Of Urine Tests

The key advantages of urine tests include non-invasiveness, ease of collection, and suitability for large-scale screenings (Khamis et al., 2017; Zhan et al., 2025). Unlike blood draws or tissue biopsies, urine collection does not require specialized medical personnel, minimizing patient discomfort and reducing the risk of complications such as infections. This simplicity makes urine testing particularly valuable in community health initiatives, epidemiological studies, and low-resource settings where access to healthcare infrastructure may be limited. 

Additionally, urine can provide a rich source of biomarkers for a wide range of conditions. These biomarkers are leukocytes, nitrites, urobilinogen, protein, pH, blood, specific gravity, ketones, bilirubin, glucose, magnesium, sodium, calcium, oxidative stress, creatinine, microalbumin,  and vitamin C (Kassa et al., 2002; Abebayehu, 2023; Çebi et al., 2024). Several hormones can be detected in urine, often for diagnostic or monitoring purposes. These hormones are human chorionic gonadotropin (hCG), luteinizing hormone (LH), follicle-stimulating hormone (FSH), estrogen, progesterone, cortisol and testosterone (Hafez et al., 2000; Barbieri, 2014; Babaniyi et al., 2024). Also, some sexually transmitted diseases (STDs) that can be detected through urine tests, particularly using lateral flow assays (LFA). These STDs are Chlamydia trachomatis, Neisseria gonorrhoeae (Gonorrhea), Trichomonas vaginalis (Trichomoniasis), Herpes Simplex Virus (HSV-1 and HSV-2).

Very dilute or very concentrated urine can affect the accuracy of readings (Pradella et al., 1988; Chadha et al., 2001; Abebayehu, 2023). That's why specific gravity is often measured alongside other markers. Abnormal results (e.g., proteinuria, hematuria) indicate a problem but not the exact diagnosis, and further testing (blood tests, imaging, biopsy) is usually needed. When using manual urine strips, results can be subjective, depending on the lighting, timing, and human interpretation. However, an AI integrated application, like Vivoo, has a high-accuracy image processing system that provides results without alteration by light, shadow, or human interpretation, ensuring more reliable and standardized readings (Caf et al., 2023; Çelik et al., 2024).

Advantages of Urine Testing:

  • Urine biomarkers enable the early detection of various diseases.

  • They provide a rich source of biological information.

  • Sample collection is straightforward and non-invasive.

  • Urine test results are less influenced by internal regulatory mechanisms.

  • Ideal for continuous health monitoring.

  • Suitable for individuals who have difficulty undergoing blood draws.

  • Urine can be collected in flexible volumes, from small to large amounts.

  • Samples are easy to store, transport, and manage.

  • Collection can take place conveniently at home, in the office, at school, or other locations.

  • Urine tests are typically more affordable than blood tests.

  • There is no risk of infection, injury, or other complications related to needle use.

  • Urine analysis can detect infections, metabolic conditions, drug use, hydration levels, kidney and liver health, and nutritional status.

  • Samples can usually be collected by individuals themselves without the need for professional assistance.

Figure 1: Cycle of urine testing benefits. Adapted from Zhang et al., 2022, Frontiers in Analytical Science, under the terms of the Creative Commons Attribution License (CC BY). Figure generated by using Napkin.ai.

How Accurate Are Urine Testing Strips?

Urine testing strips offer reliable semi-quantitative results for screening purposes but have limitations in sensitivity and specificity compared to laboratory-based assays (Price, 2001). Studies show that while strips provide high accuracy for parameters like glucose and protein (Lenaerts et al., 2020), proper handling and timing are critical to minimize false positives or negatives (Simerville et al., 2005). Urine testing has been significantly enhanced by the integration of artificial intelligence (AI). 

AI algorithms can analyze complex patterns in urine biomarkers with greater speed and precision than traditional methods, improving the accuracy of disease detection and prognosis (Kim et al., 2024; Liu et al., 2024). Machine learning models can also identify subtle changes over time, enabling earlier intervention and more personalized healthcare. As a result, AI-driven urine analysis is emerging as a powerful tool in both clinical and home-based health monitoring (Tan et al., 2021; Shukla et al., 2023; Kim et al., 2024).

To address these challenges, the Vivoo Wellness Test is designed to provide effortless, at-home screening of urine for a range of important health parameters, including specific gravity, magnesium, calcium, vitamin C, ketones, pH, sodium, and oxidative stress. Vivoo enhances traditional urine strip testing by combining it with an artificial intelligence-based image processing system integrated into the Vivoo App. 

This advanced technology enables users to obtain highly accurate, objective results without the variability introduced by lighting, shadows, or human interpretation errors. By ensuring a consistent and standardized analysis, Vivoo offers users an accessible and reliable tool for proactive health monitoring in everyday life (Caf et al., 2023; Çelik et al., 2024).

Why Analyze Blood?

Blood analysis remains the gold standard for diagnosing acute illnesses, monitoring systemic inflammation, organ function, and hormone levels (Greene et al., 2019). Blood tests can detect biomarkers at very low concentrations, providing high sensitivity for early disease detection (Gao, 2018). Additionally, blood sampling allows for a broad range of assays, including molecular diagnostics and immunological profiling.

Benefits And Limitations Of Blood Tests

The advantages of blood tests include precise measurement of biomarkers and real-time physiological insights (Gao, 2018). However, blood draws are invasive, may require trained personnel, and can pose risks such as infection, hematoma, and discomfort (Greene et al., 2019). Frequent blood testing is impractical for wellness monitoring due to cost and invasiveness.

Although blood tests are considered the gold standard for diagnosing many medical conditions, they have several limitations, particularly in the context of wellness testing. Blood sampling often requires venipuncture by trained professionals, which can cause discomfort, anxiety, and even complications such as hematoma or infection (World Health Organization, 2010). Moreover, blood draws may deter individuals from participating in routine health checks, especially in community-based or at-home wellness initiatives. In contrast, non-invasive methods like urine testing, as utilized by Vivoo, offer a more practical and user-friendly alternative.

When Should You Choose A Urine Test Or A Blood Test?

Urine tests are preferred for non-invasive monitoring of hydration, kidney health, urinary tract infections, and metabolic waste analysis (Bouatra et al., 2013). They are also effective for tracking essential minerals such as sodium, potassium, calcium, magnesium, and phosphate, which reflect dietary intake and overall mineral balance (Kara et al., 2013; Heaney, 2015; Zhang et al., 2017). This makes urine sampling valuable in assessing risks for conditions such as kidney stones, osteoporosis, and electrolyte imbalances. 

In contrast, blood tests are chosen when detailed systemic information is needed, such as evaluating organ function, infectious diseases, or hormonal imbalances (Greene et al., 2019). The choice of test depends on the clinical question, the required sensitivity, and user convenience. Urine is more suitable for daily testing, especially for longitudinal monitoring of hydration status, metabolic waste, and mineral excretion. If you would like to monitor your body's wellness on a daily basis, urine is the best option.

Why Vivoo Uses Urine for Wellness Insights?

Vivoo leverages urine testing because it aligns with the need for frequent, comfortable, at-home wellness monitoring without clinical barriers. Urine biomarkers offer actionable insights into hydration, nutrition, oxidative stress, and metabolic status, empowering users to take preventive health measures easily. 

Furthermore, urine analysis supports Vivoo’s mission of democratizing access to personalized wellness data outside traditional healthcare settings. Vivoo uses urine to enable individuals to monitor their health conveniently, regularly, and with high precision, making advanced diagnostics more accessible for daily wellness management.

Join our newsletter & get an extra 10% off!

Get customized content for every stage of your journey directly in your inbox.

Back to blog
img author
Haluk Çelik

Written by Senior R&D Engineer, Haluk Çelik on April 29, 2025.

Table of Contents

What’s The Difference Between A Blood Test And A Urine Test?

Why Analyze Urine?

How Is A Urine Test Conducted?

Advantages And Limitations Of Urine Tests

Advantages of Urine Testing:

How Accurate Are Urine Testing Strips?

Why Analyze Blood?

Benefits And Limitations Of Blood Tests

When Should You Choose A Urine Test Or A Blood Test?

Why Vivoo Uses Urine for Wellness Insights?

Article Review History

  • References
  1. Abebayehu, A. (2023). Urine test strip analysis, concentration range and its interpretations of the parameters. GSC Biological and Pharmaceutical Sciences, 22(2), 1-13.
  2. Ahangar, M., Mahjoubi, F., & Mowla, S. J. (2024). Bladder cancer biomarkers: current approaches and future directions. Frontiers in Oncology, 14, 1453278.
  3. Akagawa, Y., Kimata, T., Akagawa, S., Fujishiro, S., Kato, S., Yamanouchi, S., ... & Kaneko, K. (2020). Optimal bacterial colony counts for the diagnosis of upper urinary tract infections in infants. Clinical and Experimental Nephrology, 24, 253-258.
  4. Babaniyi, G. G., Ajao, B. H., Akor, U. J., & Babaniyi, E. (2024). Reproductive endocrinology drug development: Hormones, metabolism, and fertility in female reproductive health. In Perspectives of Quorum Quenching in New Drug Development (pp. 187-206). CRC Press.
  5. Balhara, N., Devi, M., Balda, A., Phour, M., & Giri, A. (2023). Urine; a new promising biological fluid to act as a non-invasive biomarker for different human diseases. Urine, 5, 40-52.
  6. Barbieri, R. L. (2014). The endocrinology of the menstrual cycle. Human fertility: methods and protocols, 145-169
  7. Bouatra, S., Aziat, F., Mandal, R., Guo, A. C., Wilson, M. R., Knox, C., ... & Wishart, D. S. (2013). The human urine metabolome. PLoS ONE, 8(9), e73076. https://doi.org/10.1371/journal.pone.0073076
  8. Caf, B. B., Çebi, G., Çelik, H., Noroozi, A., Atasever, A., & Tayfun, M. (2023). Smartphone-Based Point-of-Care Urinalysis Vivoo App: A Validation Study. International Journal of Life Sciences and Biotechnology, 7(1), 60-73.
  9. Chadha, V., Garg, U., & Alon, U. S. (2001). Measurement of urinary concentration: a critical appraisal of methodologies. Pediatric Nephrology, 16, 374-382.
  10. Cheriyan, A., Nellickal, A. J., John, N. T., Jeyaseelan, L., Kumar, S., Devasia, A., & Kekre, N. (2021). Diagnostic accuracy of urinary aquaporin-1 as a biomarker for renal cell carcinoma. Indian Journal of Urology, 37(1), 59-64.
  11. Çebi, G., Caf, B. B., Kozan, E., Derman, S., Çelik, H., & Tayfun, M. (2024). Evaluation of Traceability of Dietary Urine Biochemistry Changes with Commercial Urine Strips. Clinical and Experimental Health Sciences, 14(2), 494-500.
  12. Çelik, H., Caf, B. B., Geyik, C., Çebi, G., & Tayfun, M. (2024). Enhancing urinalysis with smartphone and AI: a comprehensive review of point-of-care urinalysis and nutritional advice. Chemical Papers, 78(2), 651-664.
  13. Dunn, W. B., Broadhurst, D., Ellis, D. I., Brown, M., & Goodacre, R. (2011). Metabolomics: Applications to the study of human disease. Trends in Analytical Chemistry, 30(9), 1349–1360. https://doi.org/10.1016/j.trac.2011.04.007
  14. Filella, X., & Foj, L. (2016). Prostate cancer detection and prognosis: from prostate specific antigen (PSA) to exosomal biomarkers. International journal of molecular sciences, 17(11), 1784.
  15. Flitcroft, J. G., Verheyen, J., Vemulkar, T., Welbourne, E. N., Rossi, S. H., Welsh, S. J., ... & Stewart, G. D. (2022). Early detection of kidney cancer using urinary proteins: a truly non‐invasive strategy. BJU international, 129(3), 290-303.
  16. Gan, J., Zeng, X., Wang, X., Wu, Y., Lei, P., Wang, Z., ... & Hu, Z. (2022). Effective diagnosis of prostate cancer based on mRNAs from urinary exosomes. Frontiers in medicine, 9, 736110.
  17. Gao, X. (2018). Recent advances and challenges in blood biomarker analysis. Clinica Chimica Acta, 482, 109-114. https://doi.org/10.1016/j.cca.2018.03.013
  18. Greene, D. N., Roberts, W. L., & Bachmann, L. M. (2019). Blood testing in medical practice. New England Journal of Medicine, 380(4), 330-340. https://doi.org/10.1056/NEJMra1813605.
  19. Hafez, E. S. E., Jainudeen, M. R., & Rosnina, Y. (2000). Hormones, growth factors, and reproduction. Reproduction in farm animals, 31-54.
  20. Heaney, R. P. (2015). Sodium, potassium, phosphorus, and magnesium. Nutrition and bone health, 379-393.
  21. Kassa, A., Wolde, M., & Kibret, B. (2002). Urinalysis. Ethiopia Publik Health Training Initiative, Ethiopia.
  22. Kara, P. S., Erkoc, R., Soyoral, Y. U., Begenik, H., & Aldemir, M. N. (2013). Correlation of 24-hour urine sodium, potassium and calcium measurements with spot urine. European Journal of General Medicine, 10(1), 20-25.
  23. Khamis, M. M., Adamko, D. J., & El-Aneed, A. (2017). Mass spectrometric based approaches in urine metabolomics and biomarker discovery. Mass Spectrometry Reviews, 36(2), 115-134. https://doi.org/10.1002/mas.21459
  24. Kim, H. J., Kim, M., Zhang, H., Kim, H. R., Jeon, J. W., Seo, Y., & Choi, Q. (2024). Artificial Intelligence in Diagnostics: Enhancing Urine Test Accuracy Using a Mobile Phone–Based Reading System. Annals of Laboratory Medicine, 45(2), 178.
  25. Lemos, A. E. G., da Rocha Matos, A., & Ferreira, L. B. (2019). The long non-coding RNA PCA3: an update of its functions and clinical applications as a biomarker in prostate cancer. Oncotarget, 10(61), 6589.
  26. Lenaerts, K., Van den Berghe, L., & Rutgeerts, P. (2020). Clinical utility of point-of-care urine testing. Annals of Clinical Biochemistry, 57(2), 104-114. https://doi.org/10.1177/0004563219884197.
  27. Lepowsky, E., Ghaderinezhad, F., Knowlton, S., & Tasoglu, S. (2017). based assays for urine analysis. Biomicrofluidics, 11(5).
  28. Liu, T. J., Yang, W. C., Huang, S. M., Yang, W. L., Wu, H. J., Ho, H. W., ... & Chu, P. Y. (2024). Evaluating artificial intelligence–enhanced digital urine cytology for bladder cancer diagnosis. Cancer Cytopathology, 132(11), 686-695.
  29. Morrissey, J. J., Mellnick, V. M., Luo, J., Siegel, M. J., Figenshau, R. S., Bhayani, S., & Kharasch, E. D. (2015). Evaluation of urine aquaporin-1 and perilipin-2 concentrations as biomarkers to screen for renal cell carcinoma: a prospective cohort study. JAMA oncology, 1(2), 204-212.
  30. Morrissey, J. J., & Kharasch, E. D. (2013). The specificity of urinary aquaporin 1 and perilipin 2 to screen for renal cell carcinoma. The Journal of urology, 189(5), 1913-1920.
  31. Poletaev, A. (2018). Composition of the Blood and Reflection of the Health State of Human Body. Biomedical and Pharmacology Journal, 11(4), 1797-1800.
  32. Pradella, M., Dorizzi, R. M., Rigolin, F., & Statland, B. E. (1988). Relative density of urine: methods and clinical significance. CRC Critical reviews in clinical laboratory sciences, 26(3), 195-242.
  33. Price, C. P. (2001). Urinalysis: The clinical chemistry of urine. Annals of Clinical Biochemistry, 38(6), 656-678. https://doi.org/10.1258/0004563011901137. 
  34. Ridley, J. W. (2018). Fundamentals of the study of urine and body fluids (pp. 1-6). Berlin/Heidelberg: Springer.
  35. Santos-Silva, M. A., Sousa, N., & Sousa, J. C. (2024). Artificial intelligence in routine blood tests. Frontiers in Medical Engineering, 2, 1369265.
  36. Sequeira-Antunes, B., & Ferreira, H. A. (2023). Urinary biomarkers and point-of-care urinalysis devices for early diagnosis and management of disease: a review. Biomedicines, 11(4), 1051.
  37. Shao, Y., Wang, Y., Guan, Y., Fan, Y., & Zhang, Y. (2021). Urine metabolomics and its applications in kidney diseases. Frontiers in Medicine, 8, 676658. https://doi.org/10.3389/fmed.2021.676658
  38. Sharp, V. J., Antes, L. M., Sanders, M. L., & Lockwood, G. M. (2020). Urine Tests. Springer International Publishing.
  39. Shukla, V. K., Sudhi, M., Shetty, D. K., Banthia, S., Ch, P., Naik, N., ... & Balakrishnan, J. M. (2023). Transforming disease diagnosis and management: a comprehensive review of AI-driven urine analysis in clinical medicine. Engineered Science, 26(2), 1009.
  40. Simerville, J. A., Maxted, W. C., & Pahira, J. J. (2005). Urinalysis: A comprehensive review. American Family Physician, 71(6), 1153-1162.
  41. Strasinger, S. K., & Di Lorenzo, M. S. (2014). Urinalysis and body fluids. FA Davis.
  42. Tan, J., Qin, F., & Yuan, J. (2021). Current applications of artificial intelligence combined with urine detection in disease diagnosis and treatment. Translational andrology and urology, 10(4), 1769.
  43. Vinagre, N. M. R. (2020). Biomarkers for diagnosis and surveillance of patients with bladder cancer: a comprehensive review. PQDT-Global.
  44. Wishart, D. S., Tzur, D., Knox, C., Eisner, R., Guo, A. C., Young, N., ... & Querengesser, L. (2007). HMDB: the human metabolome database. Nucleic acids research, 35(suppl_1), D521-D526.
  45. Wishart, D. S., Knox, C., Guo, A. C., Eisner, R., Young, N., Gautam, B., ... & Forsythe, I. (2009). HMDB: a knowledgebase for the human metabolome. Nucleic acids research, 37(suppl_1), D603-D610.
  46. Wishart, D. S., Jewison, T., Guo, A. C., Wilson, M., Knox, C., Liu, Y., ... & Scalbert, A. (2012). HMDB 3.0—the human metabolome database in 2013. Nucleic acids research, 41(D1), D801-D807.
  47. Wishart, D. S., Feunang, Y. D., Marcu, A., Guo, A. C., Liang, K., Vázquez-Fresno, R., ... & Scalbert, A. (2018). HMDB 4.0: the human metabolome database for 2018. Nucleic acids research, 46(D1), D608-D617.
  48. Wishart, D. S., Guo, A., Oler, E., Wang, F., Anjum, A., Peters, H., ... & Gautam, V. (2022). HMDB 5.0: the human metabolome database for 2022. Nucleic acids research, 50(D1), D622-D631.
  49. Yeasmin, S., Ammanath, G., Onder, A., Yan, E., Yildiz, U. H., Palaniappan, A., & Liedberg, B. (2022). Current trends and challenges in point-of-care urinalysis of biomarkers in trace amounts. TrAC Trends in Analytical Chemistry, 157, 116786.
  50. Zhan, J., Cai, Y., Cheng, P., Zheng, L., & Pu, K. (2025). Body fluid diagnostics using activatable optical probes. Chemical Society Reviews.
  51. Zhang, T., Chang, X., Liu, W., Li, X., Wang, F., Huang, L., ... & Zhao, Y. (2017). Comparison of sodium, potassium, calcium, magnesium, zinc, copper and iron concentrations of elements in 24-h urine and spot urine in hypertensive patients with healthy renal function. Journal of Trace Elements in Medicine and Biology, 44, 104-108.
  52. Zhang, Z., Liu, J., Cheng, Y., Chen, J., Zhao, H., & Ren, X. (2022). Urine analysis has a very broad prospect in the future. Frontiers in Analytical Science, 1, 812301.
  53. Zambrano, I. A., Demzik, A., & Bjurlin, M. A. (2021). Urinary Biomarkers: Current Status and Future Opportunities. Comprehensive Diagnostic Approach to Bladder Cancer: Molecular Imaging and Biomarkers, 163-192.
  54. Zamanzad, B. (2009). Accuracy of dipstick urinalysis as a screening method for detection of glucose, protein, nitrites and blood. East Mediterr Health J, 15(5), 1323-8.

Leave a comment

Please note, comments need to be approved before they are published.